Login | Register

Rejected Drug Could Protect Against Parkinson’s And Alzheimer’s

The journal Molecular Psychiatry recently featured two studies on latrepirdine, known as Dimebon, which revealed that the second study could be a new potential for the compound to treat Parkinson's, Alzheimer's disease, sleep disorders as well as other neurodegenerative conditions...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *